Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Cresco Labs Inc (CRLBF)

Cresco Labs Inc (CRLBF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
2 Marijuana Companies That Have Recently Turned Profits

Are these cannabis stocks worth investing in today?

CRLBF : 2.0700 (-7.17%)
GTBIF : 14.5200 (-3.20%)
Cresco vs. Tilray: Which Cannabis Stock Is a Better Buy?

Despite lingering regulatory challenges, the cannabis market is well-positioned for a steady expansion. Penny stock Cresco's solid financials and growth potential have won over analysts, while Tilray failed...

CRLBF : 2.0700 (-7.17%)
TLRY : 2.47 (-0.40%)
$SPX : 5,254.35 (+0.11%)
2 Growth Stocks With 32% to 77% Upside in 2024

While AI stocks are the center of attention right now, many other growth stocks in various industries are going unnoticed. These stocks may benefit investors in the long run.

TLRY : 2.47 (-0.40%)
$SPX : 5,254.35 (+0.11%)
CRLBF : 2.0700 (-7.17%)
2 Cannabis Stocks to Buy Hand Over Fist in March

If you wait until there's movement on marijuana reform to buy these stocks, you could miss out on some incredible gains.

CRLBF : 2.0700 (-7.17%)
GTBIF : 14.5200 (-3.20%)
1 Stock to Buy in 2024, and 1 to Avoid

Here's a closer look at one high-yield REIT that offers both growth and income, along with a struggling tech stock that has limited upside potential, according to Wall Street.

DOCU : 59.55 (+0.47%)
IIPR : 103.54 (-0.78%)
GTBIF : 14.5200 (-3.20%)
TCNNF : 12.4000 (+1.89%)
CRLBF : 2.0700 (-7.17%)
$SPX : 5,254.35 (+0.11%)
3 Cannabis Stocks Under $5 to Consider as the DEA Reviews Drug Status

As the DEA reviews the federal classification of marijuana, here's what investors need to know about these three cannabis stocks under $5.

CRLBF : 2.0700 (-7.17%)
CURLF : 5.3400 (-2.91%)
VRNOF : 5.9400 (-5.11%)
2 Growth Stocks With 35% to 150% Upside in 2024

While all eyes are on AI stocks, there are a few undervalued growth stocks that have the potential to provide investors with massive long-term returns.

ACB : 4.39 (-7.58%)
CGC : 8.63 (-9.63%)
GTBIF : 14.5200 (-3.20%)
$SPX : 5,254.35 (+0.11%)
CRLBF : 2.0700 (-7.17%)
XNCR : 22.13 (-1.29%)
Which Is the Better Cannabis Growth Stock for You: Cresco Labs or TerrAscend?

Cannabis stocks are back in style, but is either one of these multi-state operators a long-term buy?

CCHWF : 0.9434 (-17.25%)
TRSSF : 1.7200 (unch)
CRLBF : 2.0700 (-7.17%)
Why Cannabis Stocks Like Canopy Growth and Cresco Labs Plummeted Today

The prospects for de facto legalization aren't looking great.

CGC : 8.63 (-9.63%)
CRLBF : 2.0700 (-7.17%)
Where Will Cresco Labs Be in 3 Years?

This cannabis company has a lot of work to do before it'll impress the market.

CRLBF : 2.0700 (-7.17%)

Barchart Exclusives

Ford Motor vs. Toyota: Which Hybrid EV Stock Is a Better Buy?
With hybrid EVs gaining popularity, let’s find out whether shares of Ford or Toyota are a better buy. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar